Veritable Antiviral Capacity of Natural Killer Cells in Chronic HBV Infection: An Argument for an Earlier Anti-Virus Treatment

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-017-1318-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Flow Cytometric Detection of Natural Killer Cells and Natural Killer T Cells Changes in the Blood of Patients With Chronic Hepatitis C Virus Infection in an Egyptian University Hospital

International Journal of Current Microbiology and Applied Sciences
2017English

Points: Antiviral Treatment in Chronic Infection With Hepatitis B Virus

BMJ
1986English

Antiviral Treatment of Cytomegalovirus Infection: An Update

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2012English

Cost-Effectiveness Analysis of Antiviral Pharmacotherapies for Treatment of Chronic Hepatitis C Virus Infection in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Irreversible Impact of Chronic Hepatitis C Virus Infection on Human Natural Killer Cell Diversity

Cell Stress
2018English

Cell-To-Cell Contact With Hepatitis C Virus-Infected Cells Reduces Functional Capacity of Natural Killer Cells

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2011English

Natural Killer Cells Regulate Eosinophilic Inflammation in Chronic Rhinosinusitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2015English

Thio-Isoglobotrihexosylceramide, an Agonist for Activating Invariant Natural Killer T Cells

English

Telbivudine (Sebivo) in Patients With Hepatitis B Virus (HBV) Chronic Infection

Farmeconomia. Health economics and therapeutic pathways
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy